Email this article THE ANTITUMORAL MEDICATIONS
- Authors: Romanov B.K.1, Dmitrieva N.B2, Zatsepilova T.A3
-
Affiliations:
- «The Scientific Center of Expertise of Means of Medical Application» of the Ministry of Health of the Russian Federation
- «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation
- «The I.M. Sechenov First Moscow State Medical University» of the Ministry of Health of the Russian Federation
- Issue: Vol 24, No 3 (2018)
- Pages: 146-150
- Section: Articles
- URL: https://journal-vniispk.ru/0869-2106/article/view/38463
- DOI: https://doi.org/10.18821/0869-2106-2018-24-3-146-150
- ID: 38463
Cite item
Full Text
Abstract
The article presents the review of antitumoral medications for treatment registered in Russia nowadays and being at the final stage of their development - clinical studies in authorized testing centers for subsequent registration. The summarized information is presented by official sources - the State register of medications of the Ministry of Health of the Russian Federation, the Electronic Subject Heading List of Clinical Recommendations and Clinical Handbooks and prepared on their basis Orders on Standards of Medical Care. The place and role of chemotherapeutic remedies are demonstrated in relation to therapy of oncologic patients and typical schemes of application of anti-blastoma remedies in case of the most prevalent and most severe nosological forms of neoplastic diseases.
Keywords
medication, medical remedy, anti-tumor remedies, anti-blastoma remedies, chemotherapy, hormonal therapy, target therapy, photodynamic remedies, cytostatic effect, radio-pharmaceutical remedies, phase specific, cycle specific, palliative treatment, adjuvant treatment, induction of remission, support therapy
Full Text
##article.viewOnOriginalSite##About the authors
Boris K. Romanov
«The Scientific Center of Expertise of Means of Medical Application» of the Ministry of Health of the Russian Federation
Email: Romanov@expmed.ru
the deputy general director on research activities of the Scientific Center of Expertise of Means of Medical Application, 127051, Moscow, Russian Federation 127051, Moscow, Russian Federation
N. B Dmitrieva
«N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation117997, Moscow, Russian Federation
T. A Zatsepilova
«The I.M. Sechenov First Moscow State Medical University» of the Ministry of Health of the Russian Federation119991, Moscow, Russian Federation
References
- Гарин А.М., Базин И.С. Заболеваемость, смертность, отдаленные результаты и последствия лечения онкологических больных в разных странах мира. Российский онкологический журнал. 2016; 21(1-2): 11-7.
- Дмитриева Н.Б., Кукушкин Г.В. Лекарственные средства для лечения инфекционных и онкологических заболеваний: Учебное пособие. М.; 2016.
- Чиссов В.И., Давыдов М.И., ред. Онкология: Национальное руководство. М.: ГЭОТАР-Медиа; 2013.
- Аляутдин Р.Н., ред. Фармакология. М.: ГЭОТАР-Медиа; 2016.
- Авдеев С.Н., ред. Федеральное руководство по использованию лекарственных средств (Формулярная система). Выпуск XVIII. М.; 2017.
Supplementary files
